1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions-Reference-Cited by-同舟云学术

1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions

Published:2016-06-27 Issue:13 Volume:59 Page:6547-6552
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Coviello Vito¹,Marchi Beatrice¹,Sartini Stefania¹,Quattrini Luca¹,Marini Anna Maria¹,Simorini Francesca¹,Taliani Sabrina¹,Salerno Silvia¹,Orlandi Paola²,Fioravanti Anna²,Desidero Teresa Di²,Vullo Daniela³,Da Settimo Federico¹,Supuran Claudiu T.⁴,Bocci Guido²,La Motta Concettina¹

Affiliation:

1. Dipartimento di Farmacia, Università di Pisa, Via Bonanno 6, 56126 Pisa, Italy

2. Dipartimento di Medicina Clinica e Sperimentale, Università di Pisa, Via Savi 10, 56126 Pisa, Italy

3. Laboratorio di Chimica Bioinorganica, Università degli Studi di Firenze, Polo Scientifico, Via della Lastruccia 3, 50019 Sesto Fiorentino, Firenze, Italy

4. NEUROFARBA, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Firenze, Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b00616

Reference40 articles.

1. Metabolic targets for cancer therapy

2. Ten years of anti-vascular endothelial growth factor therapy

3. Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies.

4. New horizons in tumor microenvironment biology: challenges and opportunities

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer;Bioorganic Chemistry;2024-09

2. Development of a multi-targeted chemotherapeutic approach based on G-quadruplex stabilisation and carbonic anhydrase inhibition;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-06-18

3. pH regulators and their inhibitors in tumor microenvironment;European Journal of Medicinal Chemistry;2024-03

4. Discovery of non-sulfonamide carbonic anhydrase IX inhibitors through structure-based virtual screening;Physical Chemistry Chemical Physics;2024

5. Prospects for the application of inhibitors of carbonic anhydrase isoforms IX and XII in oncology;The Scientific Notes of the Pavlov University;2023-11-08